Primary prevention of cardiovascular and heart failure events With SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes
the most common side effects are gastrointestinal, including nausea, vomiting, and diarrhoea, consistent with the GLP-1 receptor agonist class
What clinical evidence supports GLP-1 effectiveness for weight loss
Focus on overall health Maintaining a balanced diet and a healthy lifestyle is not easy
it is a documented range, and the research literature has not established an optimal daily frequency for any human goal
Mari, M., Morales, A., Colell, A., Garcia-Ruiz, C